한국발생생물학회지:발생과생식 (Development and Reproduction)

  • 제14권3호
  • /
  • Pages.199-205
  • /
  • 2010
  • /
  • 2465-9525(pISSN)
  • /
  • 2465-9541(eISSN)
한국발생생물학회 (The Korean Society of Developmental Biology)
권호 표지

Effect of 6-Hydroxydopamine (6-OHDA) on the Expression of Testicular Steroidogenic Genes in Adult Rats

  • Heo, Hyun-Jin (Dept. of Green Life Science, Sangmyung University) ;
  • Ahn, Ryun-Sup (Graduate School of Complementary and Alternative Medicine, CHA Medical University) ;
  • Lee, Sung-Ho (Dept. of Green Life Science, Sangmyung University)
  • 투고 : 2010.07.20
  • 심사 : 2010.09.07
  • 발행 : 2010.09.30
PDF 다운로드
⟨ 이전 논문 다음 논문 ⟩

초록

A neurotoxin, 6-hydroxydopamine (6-OHDA) has been widely used to create animal model for Parkinson's disease (PD). The present study was undertaken to examine whether depletion of brain dopamine (DA) stores with 6-OHDA can make alteration in the activities of the testicular steroidogenesis in adult rats. Young adult male rats (3 months old) were received a single dose of 6-OHDA (200 ${\mu}g$ in 10 ${\mu}{\ell}$/animal) by intracerebroventricular (icv) injection, and sacrificed after two weeks. The mRNA levels of steroidogenesis-related enzymes were measured by qRT-PCRs. Serum testosterone levels were measured by radioimmunoassay. Single icv infusion of 6-OHDA significantly decreased the mRNA levels of CYP11A1 (control:6-OHDA group=$1:0.68{\pm}0.14$ AU, p<0.05), CYP17 (control:6-OHDA group=$1:0.72{\pm}0.13$ AU, p<0.05). There were no changes in the mRNA levels of $3{\beta}$-HSD (control:6-OHDA group=$1:0.84{\pm}0.08$ AU) and $17{\beta}$-HSD (control: 6-OHDA group=$1:0.63{\pm}0.20$ AU), though the levels tended to be decreased in the 6-OHDA treated group. Administration of 6-OHDA decreased significantly the mRNA level of StAR when compared to the level of saline-injected control animals (control:6-OHDA group=$1:0.72{\pm}0.08$ AU, p<0.05). Treatment with single dose of 6-OHDA remarkably lowered serum testosterone levels compared to the levels of control group (control:6-OHDA group=$0.72{\pm}0.24:0.13{\pm}0.03ng/m{\ell}$, p<0.05). Taken together with our previous study, the present study demonstrated that the activities of hypothalamus-pituitary-testis hormonal axis could be negatively affected by blockade of brain DA biosynthesis, and suggested the reduced reproductive potential might be resulted in the animals. More precise information on the testicular steroidogenic activities in PD patients and PD-like animals should be required prior to the generalization of the sex steroid hormone therapy to meet the highest standards for safety and efficacy.

키워드

참고문헌

  1. Bornstein SR, Rutkowski H, Vrezas I (2004) Cytokines and steroidogenesis. Mol Cell Endocrinol 215:135-141. https://doi.org/10.1016/j.mce.2003.11.022
  2. Bronner G, Royter V, Korczyn AD, Giladi N (2004) Sexual dysfunction in Parkinson's disease. J Sex Marital Ther 30:95-105. https://doi.org/10.1080/00926230490258893
  3. Cherrier MM (2009) Testosterone effects on cognition in health and disease. Front Horm Res 37:150-162.
  4. Chomzynski P, Sacchi N (1987) Single-step method of RNA isolation by RNA guanidium thiocyanate phenolchloroform extraction. Anal Biochem 162:156-159.
  5. Deumens R, Blokland A, Prickaerts J (2002) Modeling Parkinson's disease in rats: an evaluation of 6-OHDA lesions of the nigrostriatal pathway. Exp Neurol 175: 303-317. https://doi.org/10.1006/exnr.2002.7891
  6. Farmer SF (2004) Sexual wellbeing in Parkinson's 2003; disease. J Neurol Neurosurg Psychiatry 75:1232.
  7. Fratiglioni L, Qiu C (2009) Prevention of common neurodegenerative disorders in the elderly. Exp Gerontol 44:46-50. https://doi.org/10.1016/j.exger.2008.06.006
  8. Harman S, Metter EJ, Tobin JD, Pearson J, Blackman MR (2001) Longitudinal effects of aging on serum total and free testosterone levels in healthy men. J Clin Endocrinol Metab 86:274-731.
  9. Heo HJ, Ahn RS, Lee S-H (2009) Effect of 6-hydroxydopamine (6-OHDA) on the expression of hypothalamuspituitary axis hormone genes in male rats. Dev Reprod 13:257-264.
  10. Kostrzewa RM, Jacobowitz DM (1974) Pharmacological actions of 6-hydroxydopamine. Pharmacol Rev 26:199- 288.
  11. Lane EL, Soulet D, Vercammen L, Cenci MA, Brundin P (2008) Neuroinflammation in the generation of post transplantation dyskinesia in Parkinson's disease. Neurobiol Dis 32:220-228. https://doi.org/10.1016/j.nbd.2008.06.011
  12. Lavoie HA, King SR (2009) Transcriptional regulation of steroidogenic genes: STARD1, CYP11A1 and HSD3B. Exp Biol Med (Maywood) 234:880-907. https://doi.org/10.3181/0903-MR-97
  13. Lees AJ, Hardy J, Revesz T (2009) Parkinson's disease. Lancet 373:2055-2066. https://doi.org/10.1016/S0140-6736(09)60492-X
  14. Mastorakos G, Pavlatou MG, Mizamtsidi M (2006) The hypothalamic-pituitary-adrenal and the hypothalamicpituitary- gonadal axes interplay. Pediatr Endocrinol Rev 3 Suppl 1:172-181.
  15. Monda M, Viggiano A, Viggiano A, Viggiano E, Messina G, Tafuri D, De Luca V (2007) Sympathetic and hyperthermic reactions by orexin A: role of cerebral catecholaminergic neurons. Regul Pept 139:39-44. https://doi.org/10.1016/j.regpep.2006.10.002
  16. Okun MS, Walter BL, McDonald WM, Tenover JL, Green J, Junkos JL, Delong MR (2002) Beneficial effects of testosterone replacement for the nonmotor symptoms of Parkinson disease. Arch Neurol 59:1750-1753. https://doi.org/10.1001/archneur.59.11.1750
  17. Pacheco-López G, Niemi MB, Kou W, Bildhäuser A, Gross CM, Goebel MU, del Rey A, Besedovsky HO, Schedlowski M (2003) Central catecholamine depletion inhibits peripheral lymphocyte responsiveness in spleen and blood. J Neurochem 86:1024-1031.
  18. Paxinos G, Watson C (1998) The Rat Brain in Stereotaxic Coordinates fourth edition. Academic Press Inc. San Diego.
  19. Ready RE, Friedman J, Grace J, Fernandez H (2004) Testosterone deficiency and apathy in Parkinson's disease: a pilot study. J Neurol Neurosurg Psychiatry 75:1323- 1326. https://doi.org/10.1136/jnnp.2003.032284
  20. Selvage DJ, Rivier C (2003) Importance of the paraventricular nucleus of the hypothalamus as a component of a neural pathway between the brain and the testes that modulates testosterone secretion independently of the pituitary. Endocrinology 144:594-598. https://doi.org/10.1210/en.2002-220781
  21. Selvage DJ, Parsons L, Rivier C (2006) Role played by brainstem neurons in regulating testosterone secretion via a direct neural pathway between the hypothalamus and the testes. Endocrinology 147:3070-3075. https://doi.org/10.1210/en.2005-1358
  22. Selvage DJ, Lee SY, Parsons LH, Seo DO, Rivier CL (2004) A hypothalamic-testicular neural pathway is influenced by brain catecholamines, but not testicular blood flow. Endocrinology 145:1750-1759. https://doi.org/10.1210/en.2003-1441
  23. Thorner MO, Login IS (1981) Prolactin secretion as an index of brain dopaminergic function. Adv Biochem Psychopharmacol 28:503-520.
  24. Turnbull A, Rivier C (1995) Brain-periphery connections: do they play a role in mediating the effect of centrally injected interleukin-1 beta on gonadal function? Neuroimmunomodulation 2:224-235. https://doi.org/10.1159/000097200
  25. Vermeulen A (1991) Clinical review 24: androgens in the aging male. J Clin Endocrinol Metab 73:221-224. https://doi.org/10.1210/jcem-73-2-221